Seveno backs PointFit wearable patch
Seveno Capital invested in Singapore-based PointFit, which is developing a skin-adherent wearable patch for continuous lactate monitoring via sweat. The product targets endurance athletes initially with plans to expand into metabolic health and preventative care, citing a $15 billion serviceable market in endurance sports. Observers highlight technical challenges around sensor calibration, validation, and integration with clinician workflows before such devices can deliver clinical-grade longevity insights.
Why it mattersSeveno Capital backing of PointFit's lactate sweat patch forces investors to prioritize clinical validation and interoperability.
Entities Mentioned
Seveno CapitalPointFit
People Mentioned
Jean-Baptiste Roy